EMVision Medical Devices Overview
Get informed when a big investor buys or sells
+ Follow-114.92%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
EMVision Medical Devices (EMV.AX) currently reports a ROE of -114.92%. That is below the sector sector average of 11.67%. Use the charts on this page to explore EMVision Medical Devices's ROE history and peer comparisons.
EMVision Medical Devices's ROE of -114.92% is lower than the its sector sector average of 11.67%. That is roughly 1085.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but EMVision Medical Devices's current -114.92% should be judged against industry norms (sector average: 11.67%) and against EMV.AX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -114.92%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.67%. From there, open related valuation or income-statement pages for EMVision Medical Devices, and consider following EMV.AX for alerts when major investors trade the stock.
